Joint Outcome Study
A Clinical Trial of Primary Prophylaxis Against Joint Disease in Children With Severe Hemophilia
This study examines the progression of joint disease in children with hemophilia assigned to either standard treatment or enhanced therapy.
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Inclusion Criteria: - Diagnosed with hemophilia A - factor level less than 2% Exclusion Criteria: - More than 2 bleeds into the same joint
1 Year - 30 Months
Accepts Healthy Volunteers
Marilyn J Manco-Johnson, MD, ,
Centers for Disease Control and Prevention
Marilyn J Manco-Johnson, MD, Principal Investigator, University of Colorado, Denver